|
1 |
Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice
Kyeong Ok Kim
Clin Endosc.2022;55(4):480-488. Published online 2022 July 28
DOI: http://dx.doi.org/10.5946/ce.2022.108
|
|
2 |
Artificial intelligence for endoscopy in inflammatory bowel disease
Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
Intest Res.2022;20(2):165-170. Published online 2022 January 7
DOI: http://dx.doi.org/10.5217/ir.2021.00079
|
|
3 |
Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
Alexandra Cohen, Najma Ahmed, Ana Sant’Anna
Intest Res.2021;19(2):217-224. Published online 2020 April 22
DOI: http://dx.doi.org/10.5217/ir.2019.09164
|
|
4 |
Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients
So Yoon Choi, Young Ok Choi, Yon Ho Choe, Ben Kang
|
|
5 |
Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
Toshifumi Hibi, Makoto Naganuma, Eisei Oda, Yoji Yamada, Yoshitomo Chujoh, Ryoichi Yoshihara, Mamoru Watanabe
Intest Res.2020;18(1):56-68. Published online 2019 December 11
DOI: http://dx.doi.org/10.5217/ir.2019.00064
|
|
6 |
Stem cell-based therapy for inflammatory bowel disease
Hiromichi Shimizu, Kohei Suzuki, Mamoru Watanabe, Ryuichi Okamoto
Intest Res.2019;17(3):311-316. Published online 2019 July 25
DOI: http://dx.doi.org/10.5217/ir.2019.00043
|
|
7 |
The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces
Sakiko Hiraoka, Shiho Takashima, Toshihiro Inokuchi, Asuka Nakarai, Masahiro Takahara, Keita Harada, Yasuhiro Seki, Katsunori Watanabe, Jun Kato, Hiroyuki Okada
Intest Res.2019;17(2):202-209. Published online 2018 December 14
DOI: http://dx.doi.org/10.5217/ir.2018.00086
|
|
8 |
Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis
Saya Tsuda, Reiko Kunisaki, Jun Kato, Mayu Murakami, Masafumi Nishio, Tsuyoshi Ogashiwa, Takeichi Yoshida, Hideaki Kimura, Masayuki Kitano
Intest Res.2018;16(4):579-587. Published online 2018 October 10
DOI: http://dx.doi.org/10.5217/ir.2018.00021
|
|
9 |
Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh
Intest Res.2018;16(2):223-232. Published online 2018 April 30
DOI: http://dx.doi.org/10.5217/ir.2018.16.2.223
|
|
10 |
How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
You Sun Kim
|
|
11 |
Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
Vikram Narang, Ravneet Kaur, Bhavna Garg, Ramit Mahajan, Vandana Midha, Neena Sood, Ajit Sood
Intest Res.2018;16(1):55-61. Published online 2018 January 18
DOI: http://dx.doi.org/10.5217/ir.2018.16.1.55
|
|
12 |
Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target
Ben Kang, Yon Ho Choe
|
|
13 |
Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
Tadakazu Hisamatsu, Mari Hayashida
Intest Res.2017;15(3):318-327. Published online 2017 June 12
DOI: http://dx.doi.org/10.5217/ir.2017.15.3.318
|
|
14 |
The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing
Takuya Yoshino, Kohei Yamakawa, Satoshi Nishimura, Koutaro Watanabe, Shujiro Yazumi
Intest Res.2016;14(1):37-42. Published online 2016 January 26
DOI: http://dx.doi.org/10.5217/ir.2016.14.1.37
|
|